Epigenetics Market Overview
Adoption of epigenetics continues to be driven by its efficacy in suppressing contagious malignant diseases. Epigenetics deals with the study of genetics that affect the entire DNA sequence of a life form.
It also deals with gene expression where it cites the functionalities and changes the genome without involving the nucleotide sequences. Rising prevalence of different types of cancer and chronic diseases necessitate effective treatment, which is likely to boost adoption of epigenetics in the future.
Global Epigenetics Market Dynamics
Globally, prevalence of cancer and other malignant diseases continues to be an area of concern. According to WHO, cancer and other malignant disease increase the risk of death manifold. Further, WHO estimates that the number of people suffering from cancer in 2012 was 14.1 million in 2012, and this number is likely to increase to over 19 million by 2025.
Epigenetics market is also likely to receive a fillip due to funding by various government and public-private organizations. IHEC, NCI, and NIH are among the prominent organizations who are actively contributing to epigenetics research and funding.
The interest in epigenetics is traversing from developed countries and many developing countries are also focusing on epigenetics research. The use of epigenetics in finding out the ‘true age’ of an individual has also opened new avenues, especially in insure purchases and crime tracking.
However, ethical questions surrounding the use of epigenetics with respect of privacy of an individual remain.
Know More Details About the Report
High Cost Remains a Deterrent to Wider Epigenetics Adoption
The epigenetic research instruments are expensive. They are advanced in technological functionalities and high-cost maintenance and additional expenses which could affect the growth of the epigenetics market. As per current rate, instruments used for epigenetics research are in the range of % 750,00 to $900,000. Many research organizations do not have high budgets to procure these instruments, which creates challenges for wider adoption.
US and Europe Among Leading Markets for Epigenetics
US is one of the largest markets for epigenetics globally, driven by high research and funding by various organizations. High geriatric population in the region has necessitated research into novel and effective treatments. Use of epigenetics in disease treatment, backed by a robust funding mechanism is likely to provide an impetus to epigenetics adoption in the US.
In addition to US, other lucrative markets for epigenetics include UK, Germany, France, Italy, and Spain. Due to emergence of many Asian and Latin American countries as medical tourism hubs, epigenetics research is likely to witness growth.
Avail customized purchase options for your needs
Epigenetics Competition Landscape
Key companies in the epigenetics market are
- Thermo Fisher Scientific (US)
- Illumina (US)
- Zymo Research (US)
- Bio-Rad Laboratories (US)
- New England Biolabs (US)
- Active Motif (US)
- Merck Millipore (US)
- Abcam (UK)
- Agilent (US)
- QIAGEN (Netherlands)
- PerkinElmer (US)
- Diagenode (Belgium).
The epigenetics companies have espoused different strategies that include partnerships, contemporary product developments, acquisitions, and much more to stay ahead in the market and compete with the expanding market trends.
The Market Report Covers Exhaustive Analysis On:
- Market Segments
- Market Dynamics
- Market Size & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional Analysis Includes:
- North America (U.S., Canada)
- Latin America (Mexico, Brazil, Argentina, Chile, Peru)
- Europe (UK, Germany, Spain, France, BENELUX, Italy, Rest of Europe)
- East Asia (China, Japan, South Korea)
- South Asia & Oceania (India, ASEAN, Australia and New Zealand, Rest of South Asia & Oceania)
- Middle East and Africa (GCC Countries, South Africa, Northern Africa, Turkey, Rest of MEA)
- A detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company
Epigenetics Market Segmentation
- Bioinformatics Tools
- Instruments and Consumables
- DNA Methylation
- Histone Methylation
- Histone Acetylation
- MicroRNA modification
- Chromatic structures
- Cardiovascular Diseases
- Metabolic Diseases
- North America
- Middle East and Africa
- South and Central America
By End User
- Contract Research Organizations
- Pharmaceutical and Biotechnology companies
- Academic and Research Institute
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
The Rise of Intelligent Packaging
Personalized, Connected and Sustainable
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.